Key insights
- Needham raised its price target for Rocket Lab USA (RKLB) to $63, citing strong Q3 results with significant year-over-year growth in both Space Systems and Launch segments, and improved gross margins. Despite a potential delay in Neutron rocket development, optimism surrounds the Electron rocket and Haste program, with strong international bookings and potential government contracts. While revenue estimates for FY25 are up, EBITDA forecasts are
Investing.com - Needham has raised its price target on Rocket Lab USA (NASDAQ:RKLB) to $63.00 from $55.00 while maintaining a Buy rating following the company’s strong third-quarter results. The new target sits below the analyst high target of $83 but well above the current stock price of $51.24, despite InvestingPro data suggesting the stock is significantly overvalued compared to its Fair Value.
Rocket Lab reported quarterly revenue that exceeded consensus estimates by 2%, with both its Space Systems and Launch segments showing significant year-over-year growth of 36% and 95%, respectively. The company’s gross margin also improved substantially, increasing by 1,060 basis points compared to the same period last year. InvestingPro data reveals RKLB’s impressive 52.4% revenue growth over the last twelve months, with a current gross profit margin of 31.7%. The company maintains a healthy current ratio of 3.18, confirming the ProTip that RKLB "holds more cash than debt on its balance sheet."
While Needham noted that Rocket Lab’s Neutron rocket development appears to be delayed by one to two quarters, the firm expressed increased optimism about opportunities for the company’s Electron rocket and Haste program, citing strong new international bookings.
The research firm highlighted Rocket Lab’s potential to secure large government satellite contracts, specifically mentioning the Space Development Agency’s Tranche 3 program as a promising opportunity.
Needham has increased its fiscal 2025 revenue estimates for Rocket Lab while maintaining flat projections for fiscal 2026, though it reduced EBITDA forecasts for both years due to expectations of higher operating expenses.
In other recent news, Rocket Lab USA reported a 48% year-over-year increase in revenue for the third quarter of fiscal year 2025, reaching $155.1 million, surpassing the consensus estimate of $151.9 million. However, the company faced an adjusted EBITDA loss of $26.3 million, which was worse than the expected $22.0 million loss. Following these results, Citizens reiterated its Market Perform rating on the company’s stock. Meanwhile, Roth/MKM raised its price target for Rocket Lab to $75.00, maintaining a Buy rating, citing stronger margins and a growing backlog. Cantor Fitzgerald also increased its price target to $72.00, highlighting the potential of Rocket Lab’s upcoming Neutron launch vehicle. Stifel joined in raising its price target to $75.00, acknowledging the company’s strong quarterly performance and the momentum of its Electron rocket program. These developments reflect a mix of optimism and caution among analysts regarding Rocket Lab’s financial and operational progress.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.
Most traders can read a chart. The hard part is the moment: entry window open, pattern forming, and you're still waiting for more confirmation. That's the conviction gap — and our chart analysis closes it. Unlike other AIs that just read data, our Vision AI literally "sees" your charts and hands you a complete trading plan: entry, stop-loss, and profit target in under 60 seconds. Know exactly what to do next, every time.